Puma Biotechnology PBYI
NASDAQ PBYI
$9.93 +0.15 (+1.53%)
At close: Sep 30, 2026 · 4:00 PM EDT

Puma Biotechnology (PBYI) Operating Expenses (2010 - 2026)

Updated

Puma Biotechnology's Operating Expenses was $48.92 million in Q2 2026, up 6.8% from $45.8 million a year earlier and up 0.6% from the prior quarter.

Analysis

Puma Biotechnology (PBYI) Operating Expenses (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Puma Biotechnology's Operating Expenses was $200.81 million through Jun 30, 2026, up 4.6% year-over-year; for FY2025, it came in at $191.07 million, down 4.2% from FY2024.

  • Operating Expenses has now declined for seven consecutive years, with a five-year compound annual growth rate of -5.6% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $199.5 million in FY2024 (-1.7%), $203 million in FY2023 (-0.6%), $204.31 million in FY2022 (-18.9%) and $251.87 million in FY2021 (-1.4%).
  • Quarterly Operating Expenses has moved between $42.02 million (Q1 2025) and $58.46 million (Q3 2024) over five years.
  • Compared with a year earlier, Operating Expenses has increased for three straight quarters, with growth averaging 1.7% over the last eight quarters.
  • The best year-over-year quarter for Operating Expenses over five years was Q4 2025 (growth of 27.6%); the worst was Q1 2022 (a decline of 40.4%).
  • Per Business Quant data, PBYI's Operating Expenses in the three quarters before Q2 2026 was $48.64 million (Q1 2026), $58.35 million (Q4 2025) and $44.9 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.12 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.56 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -9.70 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 18.20 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 2.09 Bn
10 Puma Biotechnology 507.45 Mn 120.09 Mn 44.03 Mn 48.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 48.92 Mn
Mar 31, 2026 48.64 Mn
Dec 31, 2025 58.35 Mn
Sep 30, 2025 44.90 Mn
Jun 30, 2025 45.80 Mn
Mar 31, 2025 42.02 Mn
Dec 31, 2024 45.71 Mn
Sep 30, 2024 58.46 Mn
Jun 30, 2024 49.26 Mn
Mar 31, 2024 46.07 Mn
Dec 31, 2023 57.38 Mn
Sep 30, 2023 47.53 Mn
Jun 30, 2023 49.68 Mn
Mar 31, 2023 48.41 Mn
Dec 31, 2022 55.66 Mn
Sep 30, 2022 54.71 Mn
Jun 30, 2022 47.46 Mn
Mar 31, 2022 46.48 Mn
Dec 31, 2021 48.53 Mn
Sep 30, 2021 55.20 Mn
API Access

Puma Biotechnology Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=PBYI&period=max&api_key=YOUR_API_KEY